Key facts
- Jiangsu Hengrui Pharmaceuticals (SHG: 600276) is a other based in Shanghai, China.
About Jiangsu Hengrui Pharmaceuticals (SHG: 600276)
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
Free account
See more of the book
- ·Watchlist + alerts for Jiangsu Hengrui Pharmaceuticals (SHG: 600276)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for Jiangsu Hengrui Pharmaceuticals (SHG: 600276) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.